Our perspective on AL/ML in the life sciences industry.
In our previous post we talked about the potential of and use cases for generative AI within drug research and discovery. Today, we’ll be examining
With a new drug taking 12 years and $2.6 billion, on average, to reach the market, clinical development stakeholders are actively looking for cost-effective ways
No matter what your core focus is as a life sciences organization, manual data review is laborious and time-consuming, and vulnerable to human errors. A
In our previous blog post, we covered exactly what Chat GPT is and how it works. Let’s do a deeper dive into what it all
very time you look at your phone or computer or TV, all you see is headlines about ChatGPT and the growing array of generative AI
As with any new technology that has wide-ranging applications, artificial intelligence (AI) and machine learning (ML) are being evaluated and discussed by regulatory agencies around
In our previous blog, we talked about using AI for data management in clinical trials. We demonstrated its potential with the example of Jane —
In the first blog post of this series, we discussed what exactly Artificial Intelligence/Machine Learning (AI/ML) was by using the analogy of the marathon runner.
AI. ML. ChatGPT. There’s lots of abbreviations out there and they all have us trying to figure out what they mean — for us. Will they make our lives easier? Will they take our jobs? Welcome to our “Demystifying AI” blog series! In this initial post, we’ll talk about AI and how it works. Let’s
